Plain-English translation of NCT07347067 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether injecting medication called triamcinolone acetonide into trigger points in neck muscles is just as effective as injecting it near the occipital nerve (a major nerve at the base of your skull) for treating chronic migraine. Both approaches use the same medication, but the study wants to see if the trigger point method works as well and might be easier for doctors to perform.
Chronic migraine is common and causes real suffering, especially in older adults. Early research shows that this medication can help when injected into muscle trigger points, offering a safe and simple option for people whose migraines don't respond to regular medicines—but doctors need to know if it works as well as the nerve injection method.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive one of two injection treatments. Both involve an injection with the same medication into either your neck muscles or near the occipital nerve at the base of your skull. After treatment, you'll return for check-ins at 2 weeks, 4 weeks, 8 weeks, 12 weeks, and 24 weeks to report how your migraines are doing and any side effects you experience. The study will follow you for up to 2 years to see how long the benefit lasts.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
China